Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosisJi-Yun Lee, Kihyun Kım, Sung Hee Lim et al.|Amyloid|2014Cited by 23
Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in KoreaSeok Jin Kim, Kihyun Kım, Soo‐Youn Lee et al.|Amyloid|2013Cited by 5
A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in KoreaSang Eun Yoon, Kihyun Kım, Darae Kim et al.|International Journal of Hematology|2022Cited by 4
Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in KoreaHye Ryeon Kim, Kihyun Kım, Sang Eun Yoon et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 1
Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosisJoon Young Hur, Kihyun Kım, Sang Eun Yoon et al.|Blood Research|2021Cited by 1